↓ Skip to main content

Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival

Overview of attention for article published in Journal of Translational Medicine, March 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
28 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival
Published in
Journal of Translational Medicine, March 2020
DOI 10.1186/s12967-020-02295-y
Pubmed ID
Authors

Yohann Dabi, Cyrille Huchon, Lobna Ouldamer, Sofiane Bendifallah, Pierre Collinet, Alexandre Bricou, Emile Daraï, Marcos Ballester, Vincent Lavoue, Bassam Haddad, Cyril Touboul

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 28 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 6 21%
Researcher 6 21%
Student > Master 4 14%
Student > Ph. D. Student 2 7%
Student > Bachelor 1 4%
Other 2 7%
Unknown 7 25%
Readers by discipline Count As %
Medicine and Dentistry 12 43%
Biochemistry, Genetics and Molecular Biology 2 7%
Immunology and Microbiology 2 7%
Unspecified 1 4%
Agricultural and Biological Sciences 1 4%
Other 2 7%
Unknown 8 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 November 2022.
All research outputs
#13,585,169
of 23,172,045 outputs
Outputs from Journal of Translational Medicine
#1,606
of 4,070 outputs
Outputs of similar age
#181,462
of 367,947 outputs
Outputs of similar age from Journal of Translational Medicine
#32
of 67 outputs
Altmetric has tracked 23,172,045 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,070 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 367,947 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 67 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.